A detailed history of Qube Research & Technologies LTD transactions in Amgen Inc stock. As of the latest transaction made, Qube Research & Technologies LTD holds 247,216 shares of AMGN stock, worth $65.4 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
247,216
Previous 1,061,051 76.7%
Holding current value
$65.4 Million
Previous $332 Million 75.97%
% of portfolio
0.12%
Previous 0.53%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$309.38 - $337.38 $252 Million - $275 Million
-813,835 Reduced 76.7%
247,216 $79.7 Million
Q2 2024

Aug 14, 2024

BUY
$262.75 - $319.31 $65.3 Million - $79.3 Million
248,394 Added 30.57%
1,061,051 $332 Million
Q1 2024

May 14, 2024

BUY
$268.87 - $324.56 $209 Million - $253 Million
778,584 Added 2285.05%
812,657 $231 Million
Q4 2023

Feb 13, 2024

SELL
$255.7 - $288.46 $8.86 Million - $9.99 Million
-34,634 Reduced 50.41%
34,073 $9.81 Million
Q3 2023

Nov 13, 2023

SELL
$218.65 - $271.46 $104 Million - $129 Million
-474,024 Reduced 87.34%
68,707 $18.5 Million
Q2 2023

Aug 14, 2023

BUY
$214.27 - $253.37 $72.7 Million - $85.9 Million
339,089 Added 166.51%
542,731 $120 Million
Q1 2023

May 15, 2023

SELL
$225.79 - $275.2 $68.9 Million - $83.9 Million
-304,998 Reduced 59.96%
203,642 $49.2 Million
Q4 2022

Feb 14, 2023

BUY
$229.03 - $291.01 $48.3 Million - $61.3 Million
210,712 Added 70.73%
508,640 $134 Million
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $64 Million - $72.1 Million
-284,994 Reduced 48.89%
297,928 $67.2 Million
Q2 2022

Aug 15, 2022

BUY
$230.71 - $256.74 $107 Million - $119 Million
465,022 Added 394.42%
582,922 $142 Million
Q1 2022

May 09, 2022

BUY
$219.27 - $242.57 $25.9 Million - $28.6 Million
117,900 New
117,900 $28.5 Million
Q4 2021

Feb 01, 2022

SELL
$198.88 - $227.6 $15.8 Million - $18.1 Million
-79,651 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$212.27 - $248.7 $13.5 Million - $15.8 Million
-63,482 Reduced 44.35%
79,651 $16.9 Million
Q2 2021

Aug 13, 2021

BUY
$233.58 - $259.14 $28.6 Million - $31.8 Million
122,607 Added 597.33%
143,133 $34.9 Million
Q1 2021

May 14, 2021

BUY
$221.91 - $258.6 $4.55 Million - $5.31 Million
20,526 New
20,526 $5.11 Million
Q2 2020

Aug 14, 2020

SELL
$197.81 - $242.74 $2.69 Million - $3.29 Million
-13,574 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$182.24 - $241.7 $2.47 Million - $3.28 Million
13,574 New
13,574 $2.75 Million
Q4 2019

Feb 13, 2020

SELL
$189.21 - $243.2 $1.03 Million - $1.32 Million
-5,435 Closed
0 $0
Q3 2019

Nov 13, 2019

SELL
$174.11 - $208.62 $1.67 Million - $2.01 Million
-9,617 Reduced 63.89%
5,435 $1.05 Million
Q2 2019

Aug 02, 2019

BUY
$166.7 - $195.41 $37,507 - $43,967
225 Added 1.52%
15,052 $2.77 Million
Q1 2019

May 15, 2019

BUY
$180.87 - $203.88 $2.68 Million - $3.02 Million
14,827 New
14,827 $2.82 Million
Q4 2018

Feb 14, 2019

SELL
$178.4 - $208.25 $3.42 Million - $3.99 Million
-19,160 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$185.29 - $208.89 $3.06 Million - $3.44 Million
16,488 Added 617.07%
19,160 $3.97 Million
Q2 2018

Aug 14, 2018

BUY
$166.05 - $186.51 $220,348 - $247,498
1,327 Added 98.66%
2,672 $493,000
Q1 2018

May 14, 2018

BUY
$169.43 - $198.0 $227,883 - $266,310
1,345 New
1,345 $229,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.